May 18, 2024

Diabetic Foot Ulcers Treatment Market is Estimated to Witness High Growth Owing to Advancements in Wound Care products

The diabetic foot ulcers treatment market includes products such as foam dressings, film dressings, alginate dressings, hydrogel dressings, hydrocolloid dressings, and hydrofiber dressings. These wound care products play a major role in healing diabetic foot ulcers by managing exudate levels, protecting the wound from microbes, and promoting a moist wound healing environment. These advanced wound dressings exert various actions such as absorption of excess exudate and maintenance of a moist wound-healing environment that facilitates cellular migration and proliferation in the healing process. The growing geriatric population suffering from diabetes and rising awareness about diabetic foot ulcer treatment options are majorly driving the demand for these wound care products. The Global diabetic foot ulcers treatment market is estimated to be valued at US$ 7.72 Bn in 2024 and is expected to exhibit a CAGR of 10. % over the forecast period 2023 to 2030.

Key Takeaways

Key players operating in the diabetic foot ulcers treatment are 3M Healthcare, Braun Melsungen AG, Smith & Nephew, Inc., Organogenesis, Inc., Derma Sciences Inc., Sigvaris Inc., Acelity L.P. Inc., Osiris, Molnlycke Health Care AB, Alkem Laboratories Ltd., Healthium Medtech, Kerecis, Podimetrics, Carmell Corporation, Paracrine, Inc., VIVEX Biologics, Inc., and PolarityTE, Inc. These key companies are focusing on new product launches and strategic collaborations for advanced wound dressings and bioengineered skin substitutes.

The diabetic foot ulcers treatment market offers significant opportunities with rising healthcare expenditure in developing nations and increasing incidence of diabetes worldwide. Further, technological advancements in tissue-engineered skin substitutes, bioactive dressings with growth factors and stem cells are expected to boost market growth over the forecast period.

Advanced wound dressings with antimicrobial properties and bioengineered skin substitutes that aid faster wound healing are some technological advancements supplementing the overall growth of the diabetic foot ulcers treatment market.

Market Drivers

Growing geriatric population suffering from diabetes is a major factor fueling the market for diabetic foot ulcers treatment products. The risk of developing diabetic foot ulcers increases with age. Additionally, increasing incidence of diabetes worldwide is boosting the demand for wound care management products. It is estimated that over 550 million people will be living with diabetes by 2030. Moreover, rising healthcare spending on chronic wound management and growing awareness regarding availabilities of innovative treatment options are further propelling the market growth. However, high costs associated with advanced wound care products may hinder the overall diabetic foot ulcers treatment market expansion to some extent during the forecast period.

Challenges in Diabetic Foot Ulcers Treatment Market

Diabetic foot ulcers are a major challenge for patients suffering from diabetes as it can lead to infections and even amputation in severe cases if not treated on time. The increasing incidence of diabetes across the globe has led to a rise in cases of diabetic foot ulcers. However, effective treatment of such ulcers still remains a challenge. High cost of new treatment options, lack of awareness about early diagnosis and treatment, non-compliance of patients to treatment are some of the major challenges being faced in this market.

SWOT Analysis
Strength: Wide range of treatment options available including dressings, bioactive agents, skin grafts, growth factors. Weakness: High cost of new advanced treatment options. Opportunity: Increasing funding for research on new drugs, devices and advanced therapy options. Threats: Non-compliance of patients to complex treatment regimens.

Geographical regions with high market concentration
North America accounts for the major share of the global diabetic foot ulcers treatment market currently due to high prevalence of diabetes and advanced healthcare infrastructure in the region. The US holds the largest market share in the North America region.

Fastest growing region
Asia Pacific region is expected to witness the highest growth over the forecast period in the diabetic foot ulcers treatment market owing to increasing prevalence of diabetes, growing healthcare expenditure, rising awareness about availability of new treatment options. Rapid economic growth in countries like India and China is also supporting market growth in the Asia Pacific region.


  1. Source: Coherent Market Insights, Public sources, Desk research
  2. We have leveraged AI tools to mine information and compile it